## **Core Concept**
Scleroderma renal crisis is a serious complication of systemic sclerosis (scleroderma) characterized by accelerated hypertension and rapid kidney failure. It is primarily driven by **renin-angiotensin-aldosterone system (RAAS) activation**, leading to severe vascular damage and fibrosis in the kidneys.

## **Why the Correct Answer is Right**
The cornerstone of treating scleroderma renal crisis is the use of **Angiotensin-Converting Enzyme (ACE) inhibitors**. These drugs block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor that also stimulates aldosterone release, thereby reducing blood pressure and decreasing the progression of renal damage. The effectiveness of ACE inhibitors in scleroderma renal crisis is well-documented, making them the first-line treatment.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While other antihypertensive drugs might be used adjunctively or in specific cases, they are not the primary treatment for scleroderma renal crisis.
- **Option B:** Similarly, other classes of medications may have roles in managing hypertension or scleroderma symptoms but are not the mainstay for treating renal crises.
- **Option D:** This option is incorrect because, although certain immunosuppressants may be used in the broader management of scleroderma, they do not directly address the acute issue of scleroderma renal crisis.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that **ACE inhibitors should be initiated even if blood pressure is not severely elevated**, as the goal is to control the RAAS pathway. Also, **patients with scleroderma should be regularly monitored for signs of renal crisis**, especially during periods of scleroderma exacerbation or when corticosteroids are used, as these can precipitate a renal crisis.

## **Correct Answer:** . ACE inhibitors.